DISCvision investigates drivers and barriers of patients and medical professionals to enhance the quality of treatment, therapy compliance, marketing and healthcare management. DISCvision has recently conducted, together with samhealth, DISC-lifestyle studies on healthcare topics commissioned by Novartis, Astellas, Roche, Bayer, Astra Zenica, MSD, Amgen, Fresenius Kabi, Celgene, Chisi, Janssen, Piere Fabre, Sanofi, Vivor Farma, and Philips and several healthcare services.